The purpose of this CodeX Use Case Project Dashboard is to provide status updates for the most significant, overarching tasks associated with each Use Case. This dashboard will act to facilitate discussions regarding Use Case progress and performance for key tasks. CodeX Use Cases projects are in one of 3 stages:
CodeX Use Cases projects are in one of 3 stages, transitioned according to the Use Case Development Guidelines:
- Use Cases are in the Discovery are ideas in the Backlog that have been proposed for future consideration, with a small group discussing, and aligning on a concept.
- Use Cases in Active Community Planning are, as the name implies, being planned with Members - Identifying necessary stakeholders, objectives, deliverables, measures of success and schedules for fast-moving phases.
- Use Case Projects in Active Community Execution are projects where models, mCODE-based FHIR IGs, implementations and pilots are currently under development, led by CodeX members.
Contact CodeX Program Management to learn more about any of the Use Cases below. Pre-Discovery and Archived Use Case Concepts can be found here. All are welcome to join the CodeX/mCODE Community of Practice to hear presentations on implementation work inside and outside of CodeX.
Use Cases and Objectives | Key Work Underway | Key Accomplishments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Active Community Execution | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enable reporting of mCODE-based cancer data from health center EHRs to a state and a private registry that are aggregating data for different reasons, substantially reducing duplication and burden while increasing reporting speed and accuracy. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EHR Endpoints for Cancer Clinical Trials (ICAREdata) Collect research-quality mCODE-based data in and share from EHRs to increase the value of real-world data for clinical trials, and reduce and potentially eliminate manual and/or duplicate data entry into case report forms. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrated Trial Matching for Cancer Patients and Providers Leverage mCODE-based data standards and open APIs that enable interoperable, scalable, and accessible clinical trial matching services to improve the ability for patients to find clinical trials for which they may be eligible. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Software to enable existing EHRs and other systems to share cancer patient data conformant to the mCODE FHIR IG, to support a variety of use cases. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Radiation Therapy Treatment Data for Cancer Leverage mCODE and extensions to enable sharing of critical radiation therapy treatment data for care coordination or data reuse (research, quality measurement, payer-required reporting). |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prior Authorization in Oncology Facilitate sharing of mCODE-based clinical data between providers and payers to reduce burden and speed authorization or requests for more information. |
Members (eviCore/Evernorth, Varian, Mettle Solutions, ASTRO, MCG, ONS, Telligen, McKesson/Ontada) have confirmed prostate radiation oncology pilot. McKesson has identified clinical level practice management/workflow SMEs to engage in workflow evaluation, technical requirements and data. They are focusing on synthetic data and test system for with a prime focus on prostate at this time Bi-weekly technical team are progressing. Workflow has been completed. Identification of Data elements (demo graphics and clinical) has been completed (see below).
Documentation found here - PA in Oncology - Documents |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Active Community Planning | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk Evaluation and Mitigation Strategies Create integrated, automated, efficient, and effective REMS programs by leveraging open data standards and creating the data infrastructure to enable REMS integration into the current workflow and data sharing across REMS stakeholders reducing undue burden |
Leadership meets weekly. Forming membership for the technical subgroup that will plan and execute on the pilot. Public meetings are scheduled for January, February, March and April 2023. Registration details follow:
The REMS use case team are presenting an update on their work at the February CodeX Community of Practice on 2/24/23 at 12:00 PM ET. Register here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discovery |
| Awaiting approval of HL7 Project Scope Statement. HL7 Project Proposal submitted and approved by Clinical Interoperability Council (CIC) with agreement to act as sponsoring work group, and co-sponsorship from the Mobile Health Work Group. Engaging interested community stakeholders, growing the member community, and identifying roles for members (i.e. potential pilot site, personal health intermediary, etc.) Solidifying phased plan for testing, validation, and proof of concept |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discovery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenomeX - FHIR Genomics Data Exchange |
Phase 0 MVP Pilot implementation that will enable Vanderbilt University Medical Center to request a FHIR based genomics report from Tempus using a restful FHIR API, receive and verify FHIR transmission and import it into the Epic Genomics Module. Establishing sub-work groups, Payload to determine data elements for transmission and Transport to determine data transmission mechanism for the next phases of work.
Transition to Planning end of January and Execution Q1 2023 |
Use case goals, value and scope defined; Champions identified and Leadership team established meeting regularly Planning for Phase 0 Pilot and Identification of focus areas for future Phases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genomics Operations: Enabling Access to Complex Genomic Information through FHIR Genomics Operations |
Engaging interested community members and preparing for an initial pilot phase focused on the Genomic Reporting IG operations in support of molecular tumor review boards
Transition from Discovery to Planning stage by the end of February 2023 |
Use case goals, value and scope defined; Champions identified and meeting regularly | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Create a solution that demonstrates the ability to author and evaluate digital quality measures using the FHIR data model and mCODE, where applicable, for value-based programs and clinical quality improvement in the oncology domain |
|
|
On Hold
Enable clinicians to use an oncology clinical pathway applications that accurately navigates to recommended treatments using mCODE-based data from the EHR. |